ky7hblCxN1t2+/NXzTR91Y0jEkJnYn0hyzIF9dPsRLo/vLKUw9nMDc4Mnw+w57JssJs8x+2NNuO4O+yzLDO1+z5cc5wDTG5KN
A:link { FONT-SIZE: 10pt; COLOR: #004080; FONT-FAMILY: "=CB=CE=CC=E5", "serif"; = TEXT-DECORATION
cancer (CC):. Ann Oncol 2020;31:s1142-1215. 24. Coleman RL, Lorusso D, Gennigens C, et al.: Results
特异性抗体药物,也是全球首个获批的PD-1/CTLA-4 免疫双抗,具有里程碑式的意义!中国自主研发抗癌药物崛起,从此国内病友也能接收到领先全球的抗癌新药治疗!来源:康方生物官网免疫治疗被誉为攻克癌症
0D/3kfOsZYVN+3PzX3/99ekJiDivE++g82GepYLyRv/Tg0Z/YOZ+5zrX2cGBvDNan1u6++RUl/cc1rqPFc+zc2MvcuH++fT55xra